IHS Chemical Week

Regions :: Western Europe :: Germany

Merck KGaA increases commitment to venture capital fund for start-up biotech firms to €100 million

7:14 AM MDT | May 16, 2013 | Deepti Ramesh

Merck KGaA says it will increase its commitment to its strategic corporate venture capital fund MS Ventures to €100 million ($129 million). MS Ventures is the corporate venture capital fund of Merck Serono, the biopharmaceutical division of Merck. MS Ventures was originally established in March 2009 with a €40 million commitment to invest in emerging biotechnology companies. The new increased commitment secures a long term mandate and will allow MS Ventures to significantly expand its investment activities while still focused on Merck Serono’s...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa